Global Dimenhydrinate Market Report, History and Forecast 2024-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application
Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare
Publisher : MRA | Format : PDF
Global Dimenhydrinate Market Report, History and Forecast 2024-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application
Dimenhydrinate, also known as Dramamine or Gravol, is an over-the-counter drug used to prevent nausea, vomiting, and dizziness caused by motion sickness.
Dimenhydrinate report published by Mr Accuracy reports reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Dimenhydrinate market is projected to reach US$ million in 2034, increasing from US$ million in 2022, with the CAGR of % during the period of 2024 to 2034. Demand from Hospital and Drug Store are the major drivers for the industry.
North America, Europe and Asia Pacific are the key regions for Dimenhydrinate industry. Among those areas, stimulated by rigid demand from downstream industries, Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2024 to 2034.
Globally, Dimenhydrinate key manufacturers include Bristol-Myers Squibb, Baxter Healthcare, Watson Laboratories, Pfizer, Nexgen Pharma, Goodwill Pharma, Hennig Arzneimittel, Zambon and Apotex, etc. Bristol-Myers Squibb, Baxter Healthcare, Watson Laboratories are top 3 players and held % sales share in total in 2022.
Dimenhydrinate can be divided into Oral and Injection, etc. Oral is the mainstream product in the market, accounting for % sales share globally in 2022.
Dimenhydrinate is widely used in various fields, such as Hospital, Drug Store and On-line,, etc. Hospital provides greatest supports to the Dimenhydrinate industry development. In 2022, global % sales of Dimenhydrinate went into Hospital filed.
Report Scope
This report, based on historical analysis (2024-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Dimenhydrinate market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report
Bristol-Myers Squibb
Baxter Healthcare
Watson Laboratories
Pfizer
Nexgen Pharma
Goodwill Pharma
Hennig Arzneimittel
Zambon
Apotex
Teva
Mylan
Cinfa
Neuraxpharm Arzneimittel
Gedeon Richter
Medrock Biotech
Strides Pharma
Fresenius
Novartis
Johnson and Johnson
Yoshindo
IFET
Bayer
Nidda Healthcare
Medifarma
Segment by Type
Oral
Injection
Hospital
Drug Store
On-line
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Dimenhydrinate market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2024 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Dimenhydrinate, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Dimenhydrinate industry.
Chapter 3Historical (2024-2022) and forecast (2024-2034) volume and revenue analysis of Dimenhydrinate in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2024 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Dimenhydrinate introduction, etc. Dimenhydrinate Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13Mr Accuracy reports’s Conclusions of Dimenhydrinate market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by Mr Accuracy reports.
Dimenhydrinate report published by Mr Accuracy reports reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Dimenhydrinate market is projected to reach US$ million in 2034, increasing from US$ million in 2022, with the CAGR of % during the period of 2024 to 2034. Demand from Hospital and Drug Store are the major drivers for the industry.
North America, Europe and Asia Pacific are the key regions for Dimenhydrinate industry. Among those areas, stimulated by rigid demand from downstream industries, Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2024 to 2034.
Globally, Dimenhydrinate key manufacturers include Bristol-Myers Squibb, Baxter Healthcare, Watson Laboratories, Pfizer, Nexgen Pharma, Goodwill Pharma, Hennig Arzneimittel, Zambon and Apotex, etc. Bristol-Myers Squibb, Baxter Healthcare, Watson Laboratories are top 3 players and held % sales share in total in 2022.
Dimenhydrinate can be divided into Oral and Injection, etc. Oral is the mainstream product in the market, accounting for % sales share globally in 2022.
Dimenhydrinate is widely used in various fields, such as Hospital, Drug Store and On-line,, etc. Hospital provides greatest supports to the Dimenhydrinate industry development. In 2022, global % sales of Dimenhydrinate went into Hospital filed.
Report Scope
This report, based on historical analysis (2024-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Dimenhydrinate market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report
By Company
Bristol-Myers Squibb
Baxter Healthcare
Watson Laboratories
Pfizer
Nexgen Pharma
Goodwill Pharma
Hennig Arzneimittel
Zambon
Apotex
Teva
Mylan
Cinfa
Neuraxpharm Arzneimittel
Gedeon Richter
Medrock Biotech
Strides Pharma
Fresenius
Novartis
Johnson and Johnson
Yoshindo
IFET
Bayer
Nidda Healthcare
Medifarma
Segment by Type
Oral
Injection
Segment by Application
Hospital
Drug Store
On-line
Segment by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Dimenhydrinate market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2024 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Dimenhydrinate, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Dimenhydrinate industry.
Chapter 3Historical (2024-2022) and forecast (2024-2034) volume and revenue analysis of Dimenhydrinate in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2024 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Dimenhydrinate introduction, etc. Dimenhydrinate Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13Mr Accuracy reports’s Conclusions of Dimenhydrinate market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by Mr Accuracy reports.